1. Home
  2. FBRX

FBRX

Forte Biosciences Inc.

Logo Forte Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 11:58am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).

Founded: N/A Country:
United States
United States
Employees: N/A City: DALLAS
Market Cap: 26.3M IPO Year: N/A
Target Price: $2.75 AVG Volume (30 days): 34.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.00 EPS Growth: N/A
52 Week Low/High: $0.38 - $1.15 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: